Genetically Modified Bacteriophages: A New Tactic Against Antibiotic Resistance
With 2 million cases of antibiotic-resistant infections occurring each year in the United States, the threat of antimicrobial resistance (AMR) is very real. The pipeline for drug development is perilous and running dry, and there are increasing challenges for combatting resistance with stewardship initiatives. How do you change prescribing and usage practices across several industries? In the face of these overwhelming odds, many are pointing to a new form of treatment for resistant infections—bacteriophages.Healthy patients
Emerging Antimicrobials and Diagnostics in AMR 2019
International Matchmaking Symposium on 19-20 November, 2019 in Amsterdam, The Netherlands.